PRLD - Prelude Therapeutics Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.00
DETAILS
HIGH:
$8.00
LOW:
$8.00
MEDIAN:
$8.00
CONSENSUS:
$8.00
UPSIDE:
72.41%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 85.9% |
| EBIT Margin | -819.6% |
| EBITDA Margin | -805.5% |
| Operating Margin | -861.3% |
| Pretax Margin | -819.6% |
| Cont. Ops Margin | -819.6% |
| Net Margin | -819.6% |
| Bottom Line Margin | -819.6% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 1.99 |
| Quick Ratio | 1.99 |
| Solvency Ratio | -1.345 |
| Cash Ratio | 0.67 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-2.25
Peers avg: 15.5
|
| PEG Ratio | 0.10 |
| Forward PEG | 0.10 |
| Price/Book | 3.25 |
| Price/Sales | 18.38 |
| Price/FCF | -3.96 |
| Price/Op Cash Flow | -3.96 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1259 |
| Debt/Equity | 0.2592 |
| Debt/Capital | 0.2058 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 2.06 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.15 |
| Operating Cash Flow Ratio | -1.062 |
| Operating Cash Flow/Sales | -463.8% |
| Free Cash Flow/Operating Cash Flow | 100.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -3.16 |
| Capital Expenditure Coverage | -840.33 |
| Dividend + Capital Expenditure Coverage | -840.33 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.16 |
| EPS | -1.293 |
| Debt/Share | 0.2312 |
| Cash/Share | 1.34 |
| Book Value/Share | 0.89 |
| Tangible BV/Share | 0.89 |
| Equity/Share | 0.89 |
| Operating Cash Flow/Share | -0.732 |
| Capital Expenditure/Share | 0.001 |
| FCF/Share | -0.732 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.952 |
| Price/Fair Value | 3.25 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -1.48 |